Surgery Partners, Inc.
SGRYNASDAQHealthcare● Active
$13.86
+$0.15(+1.06%)
Market Cap$1.8B
P/E Ratio—
52W High$24.1
52W Low$11.41
Surgery Partners, Inc. (SGRY) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SGRY · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.10B | $0.01B | $0.14B | $0.09B | $0.07B |
| Depreciation & Amort. | $0.18B | $0.15B | $0.12B | $0.11B | $0.10B |
| Stock-Based Comp. | $0.01B | $0.03B | $0.02B | $0.02B | $0.02B |
| Change in Working Capital | ($0.11B) | ($0.12B) | ($0.06B) | ($0.10B) | ($0.15B) |
| Net Cash from Operations | $0.27B | $0.30B | $0.29B | $0.16B | $0.09B |
| Investing Activities | |||||
| Capital Expenditure | ($0.08B) | ($0.09B) | ($0.09B) | ($0.08B) | ($0.06B) |
| Purchases of Investments | ($0.01B) | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.25B) | ($0.49B) | ($0.23B) | ($0.31B) | ($0.33B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.01B) |
| Debt Issued / Repaid | $0.16B | $0.45B | $0.02B | ($0.64B) | ($0.04B) |
| Net Cash from Financing | ($0.06B) | $0.26B | ($0.16B) | $0.04B | $0.32B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.20B | $0.21B | $0.20B | $0.08B | $0.03B |
| FCF Margin %(computed) | 5.91% | 6.73% | 7.47% | 3.08% | 1.33% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Surgery Partners, Inc. data
About Surgery Partners, Inc. (SGRY) Cash Flow Statement
Surgery Partners, Inc. generated operating cash flow of $0.27B and free cash flow of $0.20B for 2025 — a FCF margin of 5.91%. Capital expenditure was ($0.08B).
Frequently asked questions
SGRY · 4 questionsSurgery Partners, Inc. generated free cash flow of $0.20B for 2025, down 6.7% year-over-year.
SGRY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10